Enoxaparin injection for blood clot prevention in severe obesity
Part of Heart & circulation clinical trials.
This study compares giving enoxaparin (a blood thinner) in two different spots on the body (belly vs. thigh) for patients with severe obesity who need to prevent blood clots after surgery or hospital stay. The goal is to see which injection site works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Weigh enough that your BMI (body mass index) is over 40
- Be over 18 years old
- Need medicine to prevent blood clots (your doctor prescribes it)
- Not already on full-dose blood thinners
- Have kidney function above a certain level (creatinine clearance at least 30 mL/min)
- Not pregnant, no active bleeding, and no recent major bleeding or surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a higher dose of a blood thinner (enoxaparin) works better than the standard dose to prevent dangerous blood clots in the legs or lungs after a severe injury. It is for adults in the intensive care unit who are expected to stay more than 48 hours.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
This study compares two blood-thinning medications, rivaroxaban (a pill) and enoxaparin (a shot), to prevent dangerous blood clots after weight-loss surgery. If you are scheduled for bariatric surgery, this trial could help determine which approach works better for someone like you.
This study compares two different schedules of bemiparin (a blood thinner) to prevent dangerous blood clots after surgery in people with very high body weight. It may help find the safest and most effective dose/timing for clot prevention around the time of surgery.
This early-stage study compares how your body responds to an enoxaparin biosimilar (a new version of a blood thinner) versus the original brand Clexane. Researchers want to confirm the new version works the same way and is safe in healthy adults.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.